Biovest International Inc.(fka BVTIQ)

[Getac1ue2]

Adam Feuerstein at it again and thestreet.com. As we have known and seen this A.F. has an agenda, to flop the stock. I prefer the the writings of James Hill MD, @ gene.md a share holder with an extreme education.
I'm long and still holding since my accumlation.

http://gene.md/2010/05/20/biovest-meets-... Due Dilegence is the name of the game

From thestreet.com and comments by chance56
" http://www.thestreet.com/storycomments/10813622/1/biotech-stock-mailbag-ziopharm.html

Please visit Dr. James Hill's explanation of why the 3 month production time is not the partnership hindrance that Adam has portrayed it to be...

http://seekingalpha.com/article/206258-biovest-meets-skeptic-s-requirements-for-the-next-dendreon-part-1

This is one in a four part series that specifically addresses many of the misrepresentations of BiovaxID's potential. All four parts can be viewed on Seeking Alpha or http://gene.md/

There is a great deal of misunderstanding in regards to BiovaxID's data and the financial status of both Biovest and Accentia. Read Hill's articles, read though the court docs (settlement agreement with Laurus, plans of reorganization and disclosure statements), look at existing blood cancer treatments and also FDA regulatory precendents before taking full acceptance of Adam's opinion on this one.
By chance56 on 7/22/10 12:49 PM"